CN105396017A - 一种治疗脂肪肝的中药制剂及其制备方法 - Google Patents
一种治疗脂肪肝的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN105396017A CN105396017A CN201510961022.9A CN201510961022A CN105396017A CN 105396017 A CN105396017 A CN 105396017A CN 201510961022 A CN201510961022 A CN 201510961022A CN 105396017 A CN105396017 A CN 105396017A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- fatty liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 80
- 239000003814 drug Substances 0.000 title claims abstract description 68
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 61
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 58
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 58
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 58
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 21
- 241000628997 Flos Species 0.000 claims abstract description 21
- 238000000605 extraction Methods 0.000 claims abstract description 21
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000007873 sieving Methods 0.000 claims abstract description 3
- 238000011282 treatment Methods 0.000 claims description 48
- 239000000203 mixture Substances 0.000 claims description 32
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 20
- 241000237636 Pheretima Species 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 34
- 210000004185 liver Anatomy 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 240000003146 Lobelia chinensis Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 235000010677 Origanum vulgare Nutrition 0.000 abstract 1
- 240000007673 Origanum vulgare Species 0.000 abstract 1
- 241000218206 Ranunculus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 15
- 239000003390 Chinese drug Substances 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 230000008961 swelling Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 description 6
- 102000007330 LDL Lipoproteins Human genes 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 201000004792 malaria Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 102000004895 Lipoproteins Human genes 0.000 description 5
- 108090001030 Lipoproteins Proteins 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗脂肪肝的中药制剂及其制备方法,属于脂肪肝药剂制备技术领域。所述治疗脂肪肝的中药制剂包括以下原料:何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏。所述治疗脂肪肝的中药制剂是经过药液提取、浓缩、干燥、粉碎、过筛、灭菌等步骤制成的。本发明综合了多种中药功效,可以起到保肝、抗菌消炎、增强机体免疫功能等作用,人体吸收本发明中药制剂效果好,可增强人体的免疫力和抗应激能力,降提高人体患脂肪肝的治愈率,有效率达99%以上。
Description
技术领域
本发明属于脂肪肝药剂制备技术领域,具体涉及一种治疗脂肪肝的中药制剂及其制备方法。
背景技术
脂肪肝,是指由于各种原因引起的肝细胞内脂肪堆积过多的病变。脂肪性肝病正严重威胁国人的健康,成为仅次于病毒性肝炎的第二大肝病,已被公认为隐蔽性肝硬化的常见原因。脂肪肝是一种常见的临床现象,而非一种独立的疾病。其临床表现轻者无症状,重者病情凶猛。一般而言,脂肪肝属可逆性疾病,早期诊断并及时治疗常可恢复正常。
由于生活水平的不断提高,脂肪肝的发病率有逐渐增高和中年人群发展的趋势,因此,脂肪肝已成为近十几年来代谢病研究的热点之一,并取得了一定的进展,形成了多种有降脂作用的西药,但长期应用,多有不良反应。近年来,中医药防止脂肪肝病变的研究深受重视,目前虽有一些降脂的中药成方制剂形成,但用于血瘀阻滞能起到作用的上少,且疗效平平,特别是在升高高密度脂蛋白、降低低密度脂蛋白、甘油三脂、胆固醇等综合方面,目前尚未见有能够达到很好治疗以上症状的中成药,因此,研发一种用于治疗脂肪肝疗效好的中药制剂是趋势。
发明内容
本发明提供一种治疗脂肪肝的中药制剂及其制备方法,以解决现有治疗脂肪肝西药长期应用带来的不良反应、中药疗效不明显的问题。本发明综合了多种中药功效,可以起到保肝、抗菌消炎、增强机体免疫功能等作用,人体吸收本发明中药制剂效果好,可增强人体的免疫力和抗应激能力,有效提高人体患脂肪性肝病的治愈率。
为解决以上技术问题,本发明采用以下技术方案:
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌10-30份、槲寄生10-30份、秦皮10-30份、百部10-30份、牛至10-30份、车前子8-20份、川芎8-20份、天仙藤8-20份、黄芪8-20份、防风8-20份、白芷6-16份、葛根6-16份、蒲公英6-16份、半边莲6-16份、稀莶草6-16份、金银花4-12份、杜仲4-12份、牛蒡根4-12份、百合4-12份、地龙4-12份、鱼腥草2-6份、石菖蒲2-6份、制草乌2-6份、毛茛2-6份、阿魏2-6份。
优选地,所述的治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌15-25份、槲寄生15-25份、秦皮15-25份、百部15-25份、牛至15-25份、车前子10-18份、川芎10-18份、天仙藤10-18份、黄芪10-18份、防风10-18份、白芷8-14份、葛根8-14份、蒲公英8-14份、半边莲8-14份、稀莶草8-14份、金银花6-10份、杜仲6-10份、牛蒡根6-10份、百合6-10份、地龙6-10份、鱼腥草3-5份、石菖蒲3-5份、制草乌3-5份、毛茛3-5份、阿魏3-5份。
优选地,所述的治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌20份、槲寄生20份、秦皮20份、百部20份、牛至20份、车前子15份、川芎15份、天仙藤15份、黄芪15份、防风15份、白芷10份、葛根10份、蒲公英10份、半边莲10份、稀莶草10份、金银花8份、杜仲8份、牛蒡根8份、百合8份、地龙8份、鱼腥草4份、石菖蒲4份、制草乌4份、毛茛4份、阿魏4份。
本发明还提供一种治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到有机溶剂中,在超声波辅助提取法下提取药液;
S2:将步骤S1制得的药液过滤、浓缩,得混合物B;
S3:将步骤S2制得的混合物B干燥、粉碎、过筛、灭菌,制得治疗脂肪肝的中药制剂。
优选地,步骤S1中所述超声波辅助提取法提取药液的条件为:超声波功率为150-170W,有机溶剂浓度为50%-80%,提取温度为50-70℃,提取时间为30-50min。
优选地,步骤S2中药液过滤,浓缩至含水量10%-22%。
优选地,步骤S3中混合物B在95-105℃下干燥。
更优选地,所述混合物B在95-105℃下干燥至含水量为4%-6%。
优选地,步骤S3中过筛的条件为:过120-320目筛子。
优选地,步骤S3中灭菌的条件为:温度为135-136℃,压力为220-230KPa,时间为1-2min。
本发明的药理如下:
何首乌具有补肝、益肾、养血、祛风等功效,可治肝肾阴亏、须发早白、血虚头晕、腰膝酸软、筋骨酸痛、遗精、崩带、久痢等病症。
槲寄生具有祛风湿、补肝肾、强筋骨、安胎等功效,可治头痛、风湿痹痛、腰膝酸软、胎动不安、崩漏经多等病症。
秦皮具有清热燥湿、清肝明目、平喘止咳等功效,可治感冒、急性支气管炎、肺炎等症状。
百部具有温润肺气、止咳、杀虫等功效,可治风寒咳嗽、百日咳、肺结核、老年咳喘等症状。
牛至又名止痢草、土香薷、小叶薄荷,别名:奥勒冈草、俄力冈叶、披萨草、蘑菇草。它对金黄色葡萄球菌、伤寒杆菌、变形杆菌抗菌作用最强,对大肠杆菌、宋内痢疾杆菌和副伤寒杆菌也有较好的抗菌作用;牛至能促进健康人和急性肾炎患者的淋巴转化作用,并具有免疫调节作用。
车前子又名车前草、五根草,车轮菜,性寒,味甘,无毒,具有清热解毒、利尿渗湿、祛痰明目等功效,用于治疗水肿、痰热咳嗽、泄泻、热淋涩痛、目赤肿痛等症。
川芎味辛,性温,活血行气,祛风止痛,用于安抚神经,正头风头痛,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
天仙藤苦、温,具有宣通经隧,导达郁滞,疏肝行气,止心胃痛等功效。
黄芩具有清热燥湿、凉血安胎、解毒等功效,主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症状。
防风具有祛风解表、除湿止痛、疏肝解痉等功效,主治外感风寒、头痛项强、目眩昏涩、风寒湿痹等病症。
白芷具有祛风湿、活血排脓、生肌止痛等功效,可治头痛、牙痛、鼻渊、肠风痔漏、赤白带下、痈疽疮疡、皮肤瘙痒等病症。
葛根具有解肌退热、发表透诊、生津止渴、升阳止泻等功效,可治外感发热、头项强痛、麻疹初起、疹出不畅、温病口渴、消渴病等症状。
蒲公英具有清热解毒、消痈散结、消炎、凉血、利尿、利胆等功效,可治肝热目赤肿痛、化脓性疾病等症状。
半边莲具有利尿消肿、清热解毒等功效,可治小便不利、面目浮肿、蛇虫咬伤、胃癌肠癌、食管癌、肝癌等病症。
稀莶草具有祛风湿、利筋骨等功效,可治四肢麻痹、筋骨疼痛、腰膝无力、疟疾、急性肝炎、高血压病、疔疮肿毒等病症。
金银花具有清热解毒、疏散风热等功效,主治红肿热痛、外感风热、温病初起、热毒血痢、暑热烦渴、咽喉肿痛等症状。
杜仲具有补益肝肾、强筋壮骨、调理冲任、固经安胎等功效,可治咳嗽、腰膝酸痛、阳痿、遗精、尿频等症状。
牛蒡根具有祛风热、消肿毒等功效,可治风毒面肿、头晕、咽喉热肿、齿痛、咳嗽、消渴等症状。
百合具有解毒、理脾健胃、利湿消积、宁心安神、促进血液循环等功效,主治劳嗽、咳血、虚烦惊悸等症状。
地龙具有清热、平肝、止喘、通络等功效,主治高热烦躁、惊痫抽搐、肺热喘咳、热结尿闭等症状。
鱼腥草具有清热解毒、利尿消肿等功效,可治感冒、肺炎、肺脓疡、热痢、疟疾、水肿、淋病、白带等症状。
石菖蒲具有化痰开窍、化湿行气、祛风利痹、消肿止痛等功效,可治热病神昏、痰厥、健忘、耳鸣、耳聋、脘腹胀痛、噤口痢、风湿痹痛、跌打损伤等病症。
制草乌具有祛风、除湿、散寒、止痛等功效,可治疟疾、风寒湿痹、关节疼痛、心腹冷痛、寒疝作痛、麻醉止痛等病症。
毛茛具有祛风湿、解毒消肿等功效,可治疟疾、风湿痹痛、鹤膝风、恶疮痈肿、疼痛未溃、黄疸等病症。
阿魏具有化症消积、杀虫、截疟等功效,可治食积、胸腹胀满、冷痛、疟疾、痢疾等病症。
本发明具有以下有益效果:
(1)本发明是综合了何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏多种中药功效可以起到保肝、抗菌消炎、增强机体免疫功能等作用,是一种治疗脂肪肝的高效、安全、天然的中药制剂;
(2)人体吸收本发明中药制剂效果好,可增强人体的免疫力和抗应激能力,提高患脂肪性肝病的治愈率,有效率达99%以上;
(3)本发明采用超声波辅助提取法提取中药有效成分,提取效率快,提取率高;
(4)本发明的中药制剂是在高温高压下进行灭菌的,时间短、效果好,中药制剂保存时间长;
(5)本发明的中药制剂制备方法操作简单,生产成本低,有利于推广应用。
具体实施方式
下面结合具体实施例进行具体说明。
实施例1
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌10份、槲寄生10份、秦皮10份、百部10份、牛至10份、车前子8份、川芎8份、天仙藤8份、黄芪8份、防风8份、白芷6份、葛根6份、蒲公英6份、半边莲6份、稀莶草6份、金银花4份、杜仲4份、牛蒡根4份、百合4份、地龙4份、鱼腥草2份、石菖蒲2份、制草乌2份、毛茛2份、阿魏2份。
上述治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液,条件为:超声波功率为150W,乙醇浓度为50%,提取温度为50℃,提取时间为50min;
S2:将步骤S1制得的药液过滤,浓缩至含水量10%,得混合物B;
S3:将步骤S2制得的混合物B在95℃下干燥至含水量6%,接着粉碎,过120目筛子,所得粉末在温度为135℃,压力为220KPa下灭菌2min,制得治疗脂肪肝的中药制剂。
实施例2
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌30份、槲寄生30份、秦皮30份、百部30份、牛至30份、车前子20份、川芎20份、天仙藤20份、黄芪20份、防风20份、白芷16份、葛根16份、蒲公英16份、半边莲16份、稀莶草16份、金银花12份、杜仲12份、牛蒡根12份、百合12份、地龙12份、鱼腥草6份、石菖蒲6份、制草乌6份、毛茛6份、阿魏6份。
上述治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液,条件为:超声波功率为170W,乙醇浓度为80%,提取温度为70℃,提取时间为30min;
S2:将步骤S1制得的药液过滤,浓缩至含水量22%,得混合物B;
S3:将步骤S2制得的混合物B在105℃下干燥至含水量4%%,接着粉碎,过320目筛子,所得粉末在温度为136℃,压力为230KPa下灭菌1min,制得治疗脂肪肝的中药制剂。
实施例3
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌20份、槲寄生20份、秦皮20份、百部20份、牛至20份、车前子15份、川芎15份、天仙藤15份、黄芪15份、防风15份、白芷10份、葛根10份、蒲公英10份、半边莲10份、稀莶草10份、金银花8份、杜仲8份、牛蒡根8份、百合8份、地龙8份、鱼腥草4份、石菖蒲4份、制草乌4份、毛茛4份、阿魏4份。
上述治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液,条件为:超声波功率为160W,乙醇浓度为65%,提取温度为60℃,提取时间为40min;
S2:将步骤S1制得的药液过滤,浓缩至含水量15%,得混合物B;
S3:将步骤S2制得的混合物B在100℃下干燥至含水量5%,接着粉碎,过200目筛子,所得粉末在温度为136℃,压力为230KPa下灭菌1min,制得治疗脂肪肝的中药制剂。
实施例4
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌15份、槲寄生15份、秦皮15份、百部15份、牛至15份、车前子10份、川芎10份、天仙藤10份、黄芪10份、防风10份、白芷8份、葛根8份、蒲公英8份、半边莲8份、稀莶草8份、金银花6份、杜仲6份、牛蒡根6份、百合6份、地龙6份、鱼腥草3份、石菖蒲3份、制草乌3份、毛茛3份、阿魏3份。
上述治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液,条件为:超声波功率为155W,乙醇浓度为60%,提取温度为55℃,提取时间为45min;
S2:将步骤S1制得的药液过滤,浓缩至含水量13%,得混合物B;
S3:将步骤S2制得的混合物B在98℃下干燥至含水量6%,接着粉碎,过180目筛子,所得粉末在温度为136℃,压力为230KPa下灭菌1min,制得治疗脂肪肝的中药制剂。
实施例5
一种治疗脂肪肝的中药制剂,以重量份为单位,包括以下原料:何首乌25份、槲寄生25份、秦皮25份、百部25份、牛至25份、车前子18份、川芎18份、天仙藤18份、黄芪18份、防风18份、白芷14份、葛根14份、蒲公英14份、半边莲14份、稀莶草14份、金银花10份、杜仲10份、牛蒡根10份、百合10份、地龙10份、鱼腥草5份、石菖蒲5份、制草乌5份、毛茛5份、阿魏5份。
上述治疗脂肪肝的中药制剂的制备方法,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液,条件为:超声波功率为165W,乙醇浓度为75%,提取温度为65℃,提取时间为35min;
S2:将步骤S1制得的药液过滤,浓缩至含水量20%,得混合物B;
S3:将步骤S2制得的混合物B在102℃下干燥至含水量4%%,接着粉碎,过300筛子,所得粉末在温度为135℃,压力为220KPa下灭菌2min,制得治疗脂肪肝的中药制剂。
为验证本发明治疗脂肪肝的中药制剂的效果,通过以下试验验证。
(一)本发明的中药制剂对脂肪肝模型老鼠的作用
老鼠,雄性,体重100±10g,采用灌胃高脂乳剂的方法造模。高脂乳剂配方:猪油200g,胆固醇100g,果糖50g,蔗糖50g,胆盐10g,谷氨酸钠10g,丙二醇150ml,添少许土温-80搅拌均匀,加蒸馏水定容至1000ml。除正常对照组老鼠外,其他老鼠均灌胃高脂乳剂持续7周。
老鼠适应性饲养1周后,随机分成正常对照组、模型对照组以及中药组,每组10只。除正常组外,其它各组于每天上午9:00灌胃高脂乳剂,剂量5ml·kg-1·d-1。另外,自灌胃高脂乳剂10日后,每天下午14:00时灌胃受试物,给药6周。各组的受试物及剂量如下:
正常对照组:同体积的糊精水溶液;
模型对照组:同体积的糊精水溶液;
中药组(1-5):10g·kg-1·d-1中药制剂(分别由实施例1-5制备)。
末次给药后,戊巴比妥钠麻醉老鼠,解剖,腹主静脉取血测定血清ALT、AST,以及检测总胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白。
根据表1的试验结果可以看出,脂肪肝模型组老鼠血清ALT、AST含量与正常组相比明显升高,中药治疗组的老鼠血清ALT、AST含量与模型组相比有明显下降,具有显著性。
表1中药制剂对老鼠模型肝功能的影响
组别 | ALT(U/L) | AST(U/L) |
正常对照组 | 34.2±5.8 | 54.6±7.5 |
模型对照组 | 88.3±16.4 | 153.4±25.1 |
中药组1 | 50.6±18.1 | 62.1±15.3 |
中药组2 | 48.9±16.5 | 60.2±14.8 |
中药组3 | 49.7±17.6 | 61.4±15.1 |
中药组4 | 50.3±17.9 | 61.9±14.9 |
中药组5 | 49.3±17.4 | 61.1±14.7 |
根据表2的试验结果可以看出,本发明中药组老鼠的总胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白的水平与老鼠脂肪肝模型组相比有显著性差异,这说明本发明的中药制剂对于脂肪肝模型老鼠的预防或治疗具有很好的协同作用。
表2中药制剂对老鼠血脂的影响
组别 | TG(mmol/L) | TC(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) |
正常对照组 | 0.9±0.1 | 1.9±0.2 | 1.4±0.2 | 0.6±0.1 |
模型对照组 | 2.4±0.3 | 5.3±0.5 | 0.6±0.1 | 2.3±0.2 |
中药组1 | 1.3±0.2 | 2.4±0.4 | 0.7±0.2 | 1.0±0.4 |
中药组2 | 1.1±0.6 | 2.2±0.3 | 0.9±0.4 | 0.8±0.4 |
中药组3 | 1.2±0.5 | 2.3±0.1 | 0.8±0.3 | 0.9±0.3 |
中药组4 | 1.2±0.7 | 2.3±0.6 | 0.7±0.5 | 0.9±0.1 |
中药组5 | 1.2±0.1 | 2.2±0.5 | 0.8±0.6 | 0.9±0.5 |
(二)临床统计
本发明的治疗脂肪肝的中药制剂用于临床治疗203人,其中,男性98人,女105人,年龄最大86岁,最小28岁,病长着3年,短者半年。每日服药三次,每次1.5g,一个月为一个疗程。治疗分析:结果治疗203例,治愈201例,有效率99.01%。
(三)典型病例
病例1
李某,男,32岁,因上腹疼痛入院,饮酒后出现上腹痛,无转移放射,不断恶心、呕吐,既往有脂肪肝,一年前TG4.42mmol/L,TC7.28mmol/L,无肝炎、胆石症史,查体BP145/8kPa,心肺(-),上腹压痛,无反跳痛,移动性浊音(-),化验TG3.91mmol/L,TC8.07mmol/L,Ca2.4mmol/L,尿淀粉酶1000U/L,CT示胰腺弥漫性肿大。经服用本发明实施例1中药制剂3个月,进行抗炎降脂等治疗,症状有效缓解。
病例2
董某,女,35岁,因持续性上腹疼痛入院,进油食后出现中上腹痛,呈持续性、阵发性加重,无放射转移,伴恶心、呕吐,既往有脂肪肝,无肝炎、胆石症史。查体BP18/9.4kPa,心肺(-),腹平,上腹肌紧张,中上腹压痛明显,无反跳痛。化验示TG13.46mmol/L,TC9.1mmol/L,Ca2.12mmol/L,TG4.23mmol/L,TC6.28mmol/L。经服用本发明实施例2中药制剂2个月后病情好转,继续服用1个月治愈,后至今未出现病变。
病例3
田某,男,42岁,食欲不振、疲倦乏力、恶心、呕吐、体重减轻;诊断为脂肪肝。经过控制饮食,调整饮食结构,不吃或少吃动物性脂肪、甜食(包括含糖饮料)。多吃青菜、水果和富含纤维素的食物,以及高蛋白质的瘦肉、河鱼、豆制品等,不吃零食,睡前不加餐。经服用本发明实施例3中药制剂1个月后病情好转,继续服用2个月治愈,后至今未出现病变。
病例4
张某,男,43岁,其饮酒22年,约140-200g/d;查体B超提示脂肪肝5年,经服用本发明实施例4中药制剂2个月后病情好转,继续服用1个月治愈,后至今未出现病变。
病例5
王某,男,36岁,长期大量饮酒,后体检查出脂肪肝,在医院就诊一段时间后,检查正常,4个月后体检,肝功能异常,经服用本发明实施例5中药制剂1个月后病情好转,继续服用1个月治愈,后至今未出现病变。
以上内容不能认定本发明具体实施只局限于这些说明,对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思前提下,还可以做出若干简单推演或替换,都应当视为属于本发明由所提交的权利要求书确定的专利保护范围。
Claims (10)
1.一种治疗脂肪肝的中药制剂,其特征在于,以重量份为单位,包括以下原料:何首乌10-30份、槲寄生10-30份、秦皮10-30份、百部10-30份、牛至10-30份、车前子8-20份、川芎8-20份、天仙藤8-20份、黄芪8-20份、防风8-20份、白芷6-16份、葛根6-16份、蒲公英6-16份、半边莲6-16份、稀莶草6-16份、金银花4-12份、杜仲4-12份、牛蒡根4-12份、百合4-12份、地龙4-12份、鱼腥草2-6份、石菖蒲2-6份、制草乌2-6份、毛茛2-6份、阿魏2-6份。
2.根据权利要求1所述的治疗脂肪肝的中药制剂,其特征在于,以重量份为单位,包括以下原料:何首乌15-25份、槲寄生15-25份、秦皮15-25份、百部15-25份、牛至15-25份、车前子10-18份、川芎10-18份、天仙藤10-18份、黄芪10-18份、防风10-18份、白芷8-14份、葛根8-14份、蒲公英8-14份、半边莲8-14份、稀莶草8-14份、金银花6-10份、杜仲6-10份、牛蒡根6-10份、百合6-10份、地龙6-10份、鱼腥草3-5份、石菖蒲3-5份、制草乌3-5份、毛茛3-5份、阿魏3-5份。
3.根据权利要求2所述的治疗脂肪肝的中药制剂,其特征在于,以重量份为单位,包括以下原料:何首乌20份、槲寄生20份、秦皮20份、百部20份、牛至20份、车前子15份、川芎15份、天仙藤15份、黄芪15份、防风15份、白芷10份、葛根10份、蒲公英10份、半边莲10份、稀莶草10份、金银花8份、杜仲8份、牛蒡根8份、百合8份、地龙8份、鱼腥草4份、石菖蒲4份、制草乌4份、毛茛4份、阿魏4份。
4.一种根据权利要求1-3任一项所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,包括以下步骤:
S1:将何首乌、槲寄生、秦皮、百部、牛至、车前子、川芎、天仙藤、黄芪、防风、白芷、葛根、蒲公英、半边莲、稀莶草、金银花、杜仲、牛蒡根、百合、地龙、鱼腥草、石菖蒲、制草乌、毛茛、阿魏混合粉碎,得到混合物A,将混合物A加入到乙醇中,在超声波辅助提取法下提取药液;
S2:将步骤S1制得的药液过滤、浓缩,得混合物B;
S3:将步骤S2制得的混合物B干燥、粉碎、过筛、灭菌,制得治疗脂肪肝的中药制剂。
5.根据权利要求4所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,步骤S1中所述超声波辅助提取法提取药液的条件为:超声波功率为150-170W,有机溶剂浓度为50%-80%,提取温度为50-70℃,提取时间为30-50min。
6.根据权利要求4所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,步骤S2中药液过滤,浓缩至含水量10%-22%。
7.根据权利要求4所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,步骤S3中混合物B在95-105℃下干燥。
8.根据权利要求7所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,所述混合物B在95-105℃下干燥至含水量为4%-6%。
9.根据权利要求4所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,步骤S3中过筛的条件为:过120-320目筛子。
10.根据权利要求4所述的治疗脂肪肝的中药制剂的制备方法,其特征在于,步骤S3中灭菌的条件为:温度为135-136℃,压力为220-230KPa,时间为1-2min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510961022.9A CN105396017A (zh) | 2015-12-21 | 2015-12-21 | 一种治疗脂肪肝的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510961022.9A CN105396017A (zh) | 2015-12-21 | 2015-12-21 | 一种治疗脂肪肝的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105396017A true CN105396017A (zh) | 2016-03-16 |
Family
ID=55461999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510961022.9A Pending CN105396017A (zh) | 2015-12-21 | 2015-12-21 | 一种治疗脂肪肝的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105396017A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114848768A (zh) * | 2022-06-16 | 2022-08-05 | 何嗪 | 一种用于非酒精性脂肪肝病的治疗药物 |
CN115944640A (zh) * | 2023-01-29 | 2023-04-11 | 广西壮族自治区人民医院 | 对叶百部碱在制备防治肝脂肪变性或非酒精性脂肪肝的药物中应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488850A (zh) * | 2011-12-31 | 2012-06-13 | 黄文珍 | 治疗酒精性脂肪肝的中药组合物及其制备方法 |
-
2015
- 2015-12-21 CN CN201510961022.9A patent/CN105396017A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488850A (zh) * | 2011-12-31 | 2012-06-13 | 黄文珍 | 治疗酒精性脂肪肝的中药组合物及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114848768A (zh) * | 2022-06-16 | 2022-08-05 | 何嗪 | 一种用于非酒精性脂肪肝病的治疗药物 |
CN115944640A (zh) * | 2023-01-29 | 2023-04-11 | 广西壮族自治区人民医院 | 对叶百部碱在制备防治肝脂肪变性或非酒精性脂肪肝的药物中应用 |
CN115944640B (zh) * | 2023-01-29 | 2024-03-05 | 广西壮族自治区人民医院 | 对叶百部碱在制备治疗非酒精性脂肪肝的药物中应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103110844B (zh) | 一种治疗急性扁桃体炎中药 | |
CN104324125B (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN103751579B (zh) | 治疗鼻咽癌放疗引起口腔粘膜炎的药物组合物及其制备方法 | |
CN105396017A (zh) | 一种治疗脂肪肝的中药制剂及其制备方法 | |
CN104857210A (zh) | 一种治疗脂肪肝的中药组合制剂及其制备方法 | |
CN104547313A (zh) | 一种治疗肺癌、乳腺癌、淋巴癌的药物及制备方法 | |
CN103611099B (zh) | 一种治疗脚气的中药 | |
CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
CN104147270A (zh) | 治疗急性肝炎的中药组合物 | |
CN103721028B (zh) | 一种治疗心绞痛的药物及制备方法 | |
CN103656199B (zh) | 一种治疗肾阴不足证型咳嗽的中药 | |
CN102671032B (zh) | 一种治疗复发性口疮的中药 | |
CN105395879A (zh) | 一种治疗老年慢性支气管炎的中药 | |
CN104107357A (zh) | 一种止咳化痰颗粒及其制备方法 | |
CN105853933A (zh) | 一种用于治疗乳腺癌术后复发转移的中药制剂及制备方法 | |
CN103356984B (zh) | 一种防治女性缺铁性贫血的中药组合物 | |
CN105434662A (zh) | 一种治疗阿弗他口炎的中药制剂 | |
CN103610995A (zh) | 一种治疗牙龈炎的中药 | |
CN104784563A (zh) | 一种治疗扁桃体炎的中药制剂及其制备方法 | |
CN103816521A (zh) | 一种治疗风毒入络证型破伤风病的中药 | |
CN104606447A (zh) | 一种治疗外感发热的中药制剂 | |
CN1242808C (zh) | 一种治疗肺心病的中药 | |
CN107823424A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN105435036A (zh) | 一种治疗龟鳖感染性肝病的中药制剂及其制备方法 | |
CN105055959A (zh) | 一种治疗血热妄行型疫黄病的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160316 |
|
RJ01 | Rejection of invention patent application after publication |